ArticleJournal of cancer survivorship : research and practice2020

The value of immunotherapy for survivors of stage IV non-small cell lung cancer: patient perspectives on quality of life.

Rebekah Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.